A big-time patent settlement between Merck & Co. (NYSE: MRK) and Bristol-Myers Squibb (NYSE: BMY), Johnson & Johnson‘s (NYSE: JNJ) fourth quarter earnings report, and Aetna (NYSE: AET) and Humana‘s (NYSE: HUM) $37 billion merger bust were among the top stories in healthcare last week. Should you buy any of these stocks?